Clinic
Poudre Valley Health Care INC.
Poudre Valley Health Care INC. was paid $19.97M by Medicaid between Jan 2018 and Dec 2024, across 137 billing codes. Its largest line is 99283, emergency room visit (moderate) — 23% of everything it billed.
33Billing provider infoPOUDRE VALLEY HEALTH CARE INC.
FORT COLLINS, CO 80524
FORT COLLINS, CO 80524
33aNPI1760492714assigned 08/09/2006
33bProvider typeEmergency Care Clinic/Center
28Total paid$19.97M
24GClaims435,227
24DCodes billed137
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Emergency Care Clinic/Center providers in Colorado
Rank by total paid#1 of 23
Median peer was paid$1.29M
This provider vs. median16×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official CONCORDIA, ELIZABETH controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 61,910 | $2.55M | |
| 2019 | 59,544 | $2.47M | |
| 2020 | 43,889 | $1.48M | |
| 2021 | 68,899 | $2.49M | |
| 2022 | 76,712 | $3.96M | |
| 2023 | 74,848 | $4.35M | |
| 2024incomplete | 49,425 | $2.67M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 23% | 38,296 | 35,638 | $4.53M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 23% | 42,433 | 39,060 | $4.50M |
| 96361 | Intravenous infusion, hydration; each additional hour | 19% | 12,984 | 11,908 | $3.83M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 22,226 | 20,664 | $2.49M |
| S9480 | Intensive outpatient psychiatric services, per diem | 2.7% | 2,472 | 316 | $529K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 2.2% | 8,991 | 6,357 | $448K |
| 80053 | Comprehensive metabolic panel | 2.1% | 30,001 | 26,311 | $410K |
| A0427 | Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 2.0% | 6,808 | 5,686 | $403K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.7% | 4,018 | 3,827 | $332K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.4% | 2,761 | 830 | $288K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.4% | 7,797 | 2,227 | $284K |
| 0002A | 1.0% | 2,331 | 2,240 | $206K |
125 more codes
| A0433 | Advanced life support, level 2 (als 2) | <1% | 3,393 | $174K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 13,569 | $167K |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 4,482 | $155K |
| 0001A | <1% | 1,470 | $124K | |
| A0425 | Ground mileage, per statute mile | <1% | 27,388 | $116K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,136 | $75K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 501 | $75K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 58,206 | $53K |
| 80348 | <1% | 486 | $49K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 973 | $48K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,907 | $45K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,750 | $41K |
| 97597 | <1% | 418 | $33K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 80 | $25K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 255 | $25K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 1,224 | $24K |
| 86780 | <1% | 1,262 | $23K | |
| 84484 | <1% | 1,303 | $23K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,277 | $22K |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,073 | $21K |
| 80061 | Lipid panel | <1% | 1,113 | $20K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 302 | $19K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 203 | $18K |
| 80361 | <1% | 154 | $17K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 577 | $16K |
| 86850 | <1% | 675 | $15K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 846 | $15K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 255 | $15K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,075 | $14K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 577 | $13K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 24,220 | $12K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 51 | $10K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 40 | $10K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 119 | $9K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 43 | $9K |
| 80365 | <1% | 154 | $9K | |
| 86762 | <1% | 577 | $8K | |
| 87150 | <1% | 246 | $8K | |
| 87510 | <1% | 245 | $8K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 199 | $8K |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | <1% | 670 | $7K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 310 | $7K |
| C1776 | Joint device (implantable) | <1% | 19 | $7K |
| 87081 | <1% | 206 | $7K | |
| 80055 | <1% | 192 | $7K | |
| 87480 | <1% | 245 | $5K | |
| 80320 | <1% | 167 | $5K | |
| 85027 | <1% | 970 | $5K | |
| 86140 | <1% | 233 | $5K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 182 | $5K |
| 80306 | <1% | 3,337 | $5K | |
| J3490 | Unclassified drugs | <1% | 35,688 | $4K |
| 86769 | <1% | 94 | $4K | |
| 80349 | <1% | 93 | $4K | |
| 87660 | <1% | 245 | $4K | |
| 87340 | <1% | 558 | $4K | |
| 94625 | <1% | 162 | $4K | |
| 87653 | <1% | 53 | $4K | |
| 0352U | <1% | 132 | $3K | |
| A4649 | Surgical supply; miscellaneous | <1% | 170 | $3K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 126 | $3K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,835 | $3K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,701 | $3K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 241 | $3K |
| A0434 | Specialty care transport (sct) | <1% | 206 | $2K |
| 86901 | <1% | 573 | $2K | |
| 97161 | <1% | 20 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 7,531 | $2K |
| 85652 | <1% | 211 | $1K | |
| 84481 | <1% | 96 | $1K | |
| 82950 | <1% | 249 | $1K | |
| 84439 | <1% | 176 | $981.95 | |
| 86900 | <1% | 573 | $968.97 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 265 | $902.29 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,708 | $901.52 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 25 | $860.93 |
| 86803 | <1% | 279 | $741.04 | |
| 80324 | <1% | 14 | $638.22 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 316 | $635.83 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 58 | $543.03 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 12 | $495.00 |
| G0378 | Hospital observation service, per hour | <1% | 21 | $461.99 |
| 80359 | <1% | 14 | $426.16 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 772 | $362.48 |
| 87077 | <1% | 26 | $348.95 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 178 | $290.29 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 16 | $273.20 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 491 | $245.75 |
| 83690 | <1% | 2,308 | $228.71 | |
| 97116 | <1% | 32 | $201.10 | |
| 84466 | <1% | 12 | $193.32 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 25 | $158.75 |
| 82077 | <1% | 576 | $137.56 | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,428 | $128.94 |
| 81001 | <1% | 1,583 | $124.01 | |
| 85014 | <1% | 42 | $73.12 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 538 | $70.66 |
| 81003 | <1% | 1,136 | $56.99 | |
| 82728 | <1% | 12 | $55.11 | |
| 83735 | <1% | 12 | $52.36 | |
| 83540 | <1% | 12 | $45.01 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 891 | $38.39 |
| 83615 | <1% | 15 | $35.28 | |
| 81025 | <1% | 233 | $32.20 | |
| 82607 | <1% | 14 | $23.34 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 316 | $18.77 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,887 | $14.83 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 382 | $13.08 |
| Q3014 | Telehealth originating site facility fee | <1% | 12 | $5.40 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 2,773 | $3.68 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 50 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 25 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 53 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 16 | $0.00 |
| 97802 | 0% | 125 | $0.00 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 44 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 88 | $0.00 |
| J7999 | Compounded drug, not otherwise classified | 0% | 26 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 38 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 21 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 14 | $0.00 |
| A4217 | Sterile water/saline, 500 ml | 0% | 12 | $0.00 |
| A0080 | Non-emergency transportation, per mile - vehicle provided by volunteer (individual or organization), with no vested interest | 0% | 46 | $0.00 |
| 96376 | 0% | 15 | $0.00 | |
| 84703 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCONCORDIA, ELIZABETH (PRESIDENT/CEO, UCHEALTH)
| Provider | Location | Paid |
|---|---|---|
| University of Colorado Hospital Authority | Aurora, CO | $58.11M |
| Poudre Valley Health Care INC | Windsor, CO | $11.80M |
| University of Colorado Hospital Authority | Aurora, CO | $3.82M |
| University of Colorado Hospital Authority | Arvada, CO | $1.37M |
| Poudre Valley Health Care INC. | Fort Collins, CO | $1.29M |
| Poudre Valley Health Care INC | Windsor, CO | $1.16M |
| University of Colorado Hospital Authority | Thornton, CO | $800K |
| University of Colorado Hospital Authority | Commerce City, CO | $685K |
| Poudre Valley Health Care INC. | Fort Collins, CO | $441K |
| Poudre Valley Health Care INC. | Aurora, CO | $185K |
| Poudre Valley Health Care INC | Greeley, CO | $136K |
| University of Colorado Hospital Authority | Denver, CO | $2K |
| University of Colorado Hospital Authority | Denver, CO | $1K |
| University of Colorado Hospital Authority | Denver, CO | $409.85 |
| University of Colorado Hospital Authority | Lone Tree, CO | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.